|
1
|
Dagenais GR, Gerstein HC, Zhang X, McQueen
M, Lear S, Lopez-Jaramillo P, Mohan V, Mony P, Gupta R, Kutty VR,
et al: Variations in diabetes prevalence in low-, middle-, and
high-income countries: Results from the prospective urban and rural
epidemiological study. Diabetes Care. 39:780–787. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang L, Gao P, Zhang M, Huang Z, Zhang D,
Deng Q, Li Y, Zhao Z, Qin X, Jin D, et al: Prevalence and ethnic
pattern of diabetes and prediabetes in China in 2013. JAMA.
317:2515–2523. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Oei L, Rivadeneira F, Zillikens MC and Oei
EHG: Diabetes, diabetic complications, and fracture risk. Curr
Osteoporos Rep. 13:106–115. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lee R, Wong TY and Sabanayagam C:
Epidemiology of diabetic retinopathy, diabetic macular edema and
related vision loss. Eye Vis (Lond). 2(17)2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Nentwich MM and Ulbig MW: Diabetic
retinopathy-ocular complications of diabetes mellitus. World J
Diabetes. 6:489–499. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Duh EJ, Sun JK and Stitt AW: Diabetic
retinopathy: Current understanding, mechanisms, and treatment
strategies. JCI Insight. 2(e93751)2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hampton BM, Schwartz SG, Brantley MA Jr
and Flynn HW Jr: Update on genetics and diabetic retinopathy. Clin
Ophthalmol. 9:2175–2193. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mishra B, Swaroop A and Kandpal RP:
Genetic components in diabetic retinopathy. Indian J Ophthalmol.
64:55–61. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wihandani DM, Suastika K, Bagiada INA and
Malik SG: Polymorphisms of aldose reductase (ALR2) regulatory gene
are risk factors for diabetic retinopathy in type-2 diabetes
mellitus patients in Bali, Indonesia. Open Ophthalmol J.
12:281–288. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liu E, Kaidonis G, McComish BJ, Gillies
MC, Abhary S, Essex RW, Chang JH, Pal B, Daniell M, Lake S, et al:
MicroRNA-related genetic variants are associated with diabetic
retinopathy in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci.
60:3937–3942. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Babapoor-Farrokhran S, Jee K, Puchner B,
Hassan SJ, Xin X, Rodrigues M, Kashiwabuchi F, Ma T, Hu K,
Deshpande M, et al: Angiopoietin-like 4 is a potent angiogenic
factor and a novel therapeutic target for patients with
proliferative diabetic retinopathy. Proc Natl Acad Sci USA.
112:E3030–E3039. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hewing NJ, Weskamp G, Vermaat J, Farage E,
Glomski K, Swendeman S, Chan RV, Chiang MF, Khokha R, Anand-Apte B
and Blobel CP: Intravitreal injection of TIMP3 or the EGFR
inhibitor erlotinib offers protection from oxygen-induced
retinopathy in mice. Invest Ophthalmol Vis Sci. 54:864–870.
2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Federici M, Hribal ML, Menghini R, Kanno
H, Marchetti V, Porzio O, Sunnarborg SW, Rizza S, Serino M, Cunsolo
V, et al: Timp3 deficiency in insulin receptor-haploinsufficient
mice promotes diabetes and vascular inflammation via increased
TNF-alpha. J Clin Invest. 115:3494–3505. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Wang J, Zhang J, Chen X, Yang Y, Wang F,
Li W, Awuti M, Sun Y, Lian C, Li Z, et al: miR-365 promotes
diabetic retinopathy through inhibiting Timp3 and increasing
oxidative stress. Exp Eye Res. 168:89–99. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
D'Angelo D, Mussnich P, Sepe R, Raia M,
Del Vecchio L, Cappabianca P, Pellecchia S, Petrosino S, Saggio S,
Solari D, et al: RPSAP52 lncRNA is overexpressed in pituitary
tumors and promotes cell proliferation by acting as miRNA sponge
for HMGA proteins. J Mol Med (Berl). 97:1019–1032. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
National Institute on Alcohol Abuse and
Alcoholism. Helping patients who drink too much: A clinician's
guide: Updated 2005 edition (no. 7). US Department of Health and
Human Services, national institutes of health, national institute
on alcohol abuse and alcoholism, 2007. urihttps://my.ireta.org/sites/ireta.org/files/NIAAA_Clinicians_Guide_Helping_Patients.pdfsimplehttps://my.ireta.org/sites/ireta.org/files/NIAAA_Clinicians_Guide_Helping_Patients.pdf.
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Oliveira-Mateos C, Sánchez-Castillo A,
Soler M, Obiols-Guardia A, Piñeyro D, Boque-Sastre R,
Calleja-Cervantes ME, de Moura MC, Martínez-Cardús A, Rubio T, et
al: The transcribed pseudogene RPSAP52 enhances the oncofetal
HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent
let-7 inhibition. Nat Commun. 10(3979)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Leung A and Natarajan R: Long noncoding
RNAs in diabetes and diabetic complications. Antioxid Redox Signal.
29:1064–1073. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Strauss O: The retinal pigment epithelium
in visual function. Physiol Rev. 85:845–881. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xia T and Rizzolo LJ: Effects of diabetic
retinopathy on the barrier functions of the retinal pigment
epithelium. Vision Res. 139:72–81. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang Y, Xu C, Wang Y and Zhang X:
MicroRNA-365 inhibits ovarian cancer progression by targeting
Wnt5a. Am J Canc Res. 7:1096–1106. 2017.PubMed/NCBI
|
|
23
|
Qi J, Rice SJ, Salzberg AC, Runkle EA,
Liao J, Zander DS and Mu D: MiR-365 regulates lung cancer and
developmental gene thyroid transcription factor 1. Cell Cycle.
11:177–186. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Nie J, Liu L, Zheng W, Chen L, Wu X, Xu Y,
Du X and Han W: MicroRNA-365, down-regulated in colon cancer,
inhibits cell cycle progression and promotes apoptosis of colon
cancer cells by probably targeting cyclin D1 and Bcl-2.
Carcinogenesis. 33:220–225. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Dunmire JJ, Lagouros E, Bouhenni RA, Jones
M and Edward DP: MicroRNA in aqueous humor from patients with
cataract. Exp Eye Res. 108:68–71. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liang J, Chen M, Hughes D, Chumanevich AA,
Altilia S, Kaza V, Lim CU, Kiaris H, Mythreye K, Pena MM, et al:
CDK8 selectively promotes the growth of colon cancer metastases in
the liver by regulating gene expression of TIMP3 and matrix
metalloproteinases. Cancer Res. 78:6594–6606. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Weber BH, Vogt G, Pruett RC, Stöhr H and
Felbor U: Mutations in the tissue inhibitor of metalloproteinases-3
(TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet.
8:352–356. 1994.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li Y, Xu F, Xiao H and Han F: Long
noncoding RNA BDNF-AS inversely regulated BDNF and modulated
high-glucose induced apoptosis in human retinal pigment epithelial
cells. J Cell Biochem. 119:817–823. 2018.PubMed/NCBI View Article : Google Scholar
|
